PTEN and ovarian carcinoma: Further experiments will be developed with complementary ovarian carcinoma cell lines overexpressing HER-2 receptor to decipher the role of RhoB/PTEN cross-talk and/or expression vs the HER-2 expression level to increase our knowledge in ovarian carcinomas treatment.